Literature DB >> 21222175

A modular view of cytokine networks in atopic dermatitis.

Irit Carmi-Levy1, Bernhard Homey, Vassili Soumelis.   

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disease known for its complex pathophysiology involving several immune pathways. In the lesion, signals from barrier disruption, allergens, and microbial colonization are integrated and transmitted to diverse immune cell types, which initiate and maintain the disease. Cytokines are critical in the allergic intercellular communication networks. This review focuses on up-to-date knowledge on the role of cytokines in AD, including recently described functions as well as novel cellular sources. We propose three modules defined as the cellular source of groups of cytokines: (1) keratinocytes, (2) innate immune cells, and (3) T cells. This view enables to better position the function of novel cytokine players, such as thymic stromal lymphopoetin, IL-21, IL-25, and IL-33, in linking different modules and ultimately leading to the allergic inflammatory phenotype. Persistent efforts in the detailed characterization of cytokine networks will be fundamental for the understanding of the complex pathogenic mechanisms of the disease and for guiding targeted therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21222175     DOI: 10.1007/s12016-010-8239-6

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  71 in total

1.  Correlation of IL-31 serum levels with severity of atopic dermatitis.

Authors:  Ulrike Raap; Katja Wichmann; Manuela Bruder; Sonja Ständer; Bettina Wedi; Alexander Kapp; Thomas Werfel
Journal:  J Allergy Clin Immunol       Date:  2008-08       Impact factor: 10.793

2.  Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases.

Authors:  Massimiliano Sarra; Ivan Monteleone; Carmine Stolfi; Massimo Claudio Fantini; Pierpaolo Sileri; Giuseppe Sica; Roberto Tersigni; Thomas T Macdonald; Francesco Pallone; Giovanni Monteleone
Journal:  Inflamm Bowel Dis       Date:  2010-08       Impact factor: 5.325

3.  Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology.

Authors:  Holm H Uhlig; Brent S McKenzie; Sophie Hue; Claire Thompson; Barbara Joyce-Shaikh; Renata Stepankova; Nicolas Robinson; Sofia Buonocore; Helena Tlaskalova-Hogenova; Daniel J Cua; Fiona Powrie
Journal:  Immunity       Date:  2006-08       Impact factor: 31.745

4.  Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis.

Authors:  Emma Guttman-Yassky; Michelle A Lowes; Judilyn Fuentes-Duculan; Lisa C Zaba; Irma Cardinale; Kristine E Nograles; Artemis Khatcherian; Inna Novitskaya; John A Carucci; Reuven Bergman; James G Krueger
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

5.  A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma.

Authors:  Yui-Hsi Wang; Kui Shin Voo; Bo Liu; Chun-Yu Chen; Burcin Uygungil; William Spoede; Jonathan A Bernstein; David P Huston; Yong-Jun Liu
Journal:  J Exp Med       Date:  2010-10-04       Impact factor: 14.307

6.  Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors.

Authors:  M A Antonysamy; W C Fanslow; F Fu; W Li; S Qian; A B Troutt; A W Thomson
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

7.  Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation.

Authors:  Kei Ikeda; Hiroshi Nakajima; Kotaro Suzuki; Shin-ichiro Kagami; Koichi Hirose; Akira Suto; Yasushi Saito; Itsuo Iwamoto
Journal:  Blood       Date:  2003-01-02       Impact factor: 22.113

8.  Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice.

Authors:  Stacey R Dillon; Cindy Sprecher; Angela Hammond; Janine Bilsborough; Maryland Rosenfeld-Franklin; Scott R Presnell; Harald S Haugen; Mark Maurer; Brandon Harder; Janet Johnston; Susan Bort; Sherri Mudri; Joseph L Kuijper; Tom Bukowski; Pamela Shea; Dennis L Dong; Maria Dasovich; Francis J Grant; Luann Lockwood; Steven D Levin; Cosette LeCiel; Kim Waggie; Heather Day; Stavros Topouzis; Janet Kramer; Rolf Kuestner; Zhi Chen; Don Foster; Julia Parrish-Novak; Jane A Gross
Journal:  Nat Immunol       Date:  2004-06-06       Impact factor: 25.606

9.  TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand.

Authors:  Tomoki Ito; Yui-Hsi Wang; Omar Duramad; Toshiyuki Hori; Guy J Delespesse; Norihiko Watanabe; F Xiao-Feng Qin; Zhengbin Yao; Wei Cao; Yong-Jun Liu
Journal:  J Exp Med       Date:  2005-11-07       Impact factor: 14.307

10.  A role for TSLP in the development of inflammation in an asthma model.

Authors:  Amin Al-Shami; Rosanne Spolski; John Kelly; Andrea Keane-Myers; Warren J Leonard
Journal:  J Exp Med       Date:  2005-09-19       Impact factor: 14.307

View more
  15 in total

Review 1.  Atopic dermatitis: new trends and perspectives.

Authors:  Laurent Misery
Journal:  Clin Rev Allergy Immunol       Date:  2011-12       Impact factor: 8.667

2.  Topical application of a vitamin D analogue exacerbates atopic dermatitis and induces the atopic dermatitis-like phenotype in Stat6VT mice.

Authors:  Matthew J Turner; Sonia C Dasilva-Arnold; Qiaofang Yi; Purvi Mehrotra; Mark H Kaplan; Jeffrey B Travers
Journal:  Pediatr Dermatol       Date:  2013-07-25       Impact factor: 1.588

3.  Periostin promotes chronic allergic inflammation in response to Th2 cytokines.

Authors:  Miho Masuoka; Hiroshi Shiraishi; Shoichiro Ohta; Shoichi Suzuki; Kazuhiko Arima; Shigehisa Aoki; Shuji Toda; Naoki Inagaki; Yuichi Kurihara; Sayaka Hayashida; Satoshi Takeuchi; Kenta Koike; Junya Ono; Hirokazu Noshiro; Masutaka Furue; Simon J Conway; Yutaka Narisawa; Kenji Izuhara
Journal:  J Clin Invest       Date:  2012-06-11       Impact factor: 14.808

4.  The practical understanding and treatment of asthma.

Authors:  M Eric Gershwin; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

5.  IL-33: a novel danger signal system in atopic dermatitis.

Authors:  Ferda Cevikbas; Martin Steinhoff
Journal:  J Invest Dermatol       Date:  2012-05       Impact factor: 8.551

6.  Combinatorial code governing cellular responses to complex stimuli.

Authors:  Antonio Cappuccio; Raphaël Zollinger; Mirjam Schenk; Aleksandra Walczak; Nicolas Servant; Emmanuel Barillot; Philippe Hupé; Robert L Modlin; Vassili Soumelis
Journal:  Nat Commun       Date:  2015-04-21       Impact factor: 14.919

7.  Histamine induces proliferation in keratinocytes from patients with atopic dermatitis through the histamine 4 receptor.

Authors:  Franziska Glatzer; Maria Gschwandtner; Sarah Ehling; Kristine Rossbach; Katrin Janik; Andreas Klos; Wolfgang Bäumer; Manfred Kietzmann; Thomas Werfel; Ralf Gutzmer
Journal:  J Allergy Clin Immunol       Date:  2013-08-09       Impact factor: 10.793

8.  Mixture of Polyphenols and Anthocyanins from Vaccinium uliginosum L. Alleviates DNCB-Induced Atopic Dermatitis in NC/Nga Mice.

Authors:  Min Ju Kim; Se-Young Choung
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-23       Impact factor: 2.629

9.  Oclacitinib (APOQUEL(®)) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy.

Authors:  A J Gonzales; J W Bowman; G J Fici; M Zhang; D W Mann; M Mitton-Fry
Journal:  J Vet Pharmacol Ther       Date:  2014-02-05       Impact factor: 1.786

10.  A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis.

Authors:  Sallie B Cosgrove; Jody A Wren; Dawn M Cleaver; Kelly F Walsh; Stacey I Follis; Vickie I King; Jezaniah-Kira S Tena; Michael R Stegemann
Journal:  Vet Dermatol       Date:  2013-12       Impact factor: 1.589

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.